Liu Dongfang 4
4 · Nuvation Bio Inc. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
Liu Dongfang
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Class A Common Stock
2025-11-25$3.61/sh+10,000$36,100→ 28,000 total - Sale
Class A Common Stock
2025-11-25$7.50/sh−10,000$75,000→ 18,000 total - Exercise/Conversion
Class A Common Stock
2025-11-26$3.61/sh+10,000$36,100→ 28,000 total - Sale
Class A Common Stock
2025-11-26$8.00/sh−10,000$80,000→ 18,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-25−10,000→ 480,000 totalExercise: $3.61Exp: 2032-07-14→ Class A Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-26−10,000→ 470,000 totalExercise: $3.61Exp: 2032-07-14→ Class A Common Stock (10,000 underlying)
Footnotes (1)
- [F1]Option vested as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.